Dual specificity mitogen-activated protein kinase kinase 1 — Drug Target

All drugs that target Dual specificity mitogen-activated protein kinase kinase 1 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Kinase Inhibitor

Marketed (2)

• Cotellic · Roche · Kinase Inhibitor · Oncology
  Cotellic works by blocking the activity of two proteins, BRAF and MEK, which are involved in the growth and spread of cancer cells.
• Mektovi · Pfizer · Oncology
  Mektovi works by blocking the MEK1 enzyme, which is a key player in the signaling pathway that promotes cancer cell growth.